Protein structural disorder and ubiquitination
Protein structural disorder and ubiquitination
批准号:
7478711
负责人:
LILIA M IAKOUCHEVA
金额:
$16.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-08-02 至 2010-03-26
关键词:
Acute Kidney FailureAffectAmino Acid SequenceCell physiologyCellsCommunitiesComputational algorithmDNA DamageDataData SetDatabasesDefectDevelopmentDiseaseGenerationsHeat-Shock ResponseKidney DiseasesKnowledgeLysineMachine LearningMalignant - descriptorMalignant NeoplasmsMass Spectrum AnalysisMethodsModificationMutationNeurodegenerative DisordersNumbersNutrientOnline Mendelian Inheritance In ManOxidative StressParkinson DiseasePathway interactionsPeptide Sequence DeterminationPerformancePharmaceutical PreparationsPlayProceduresProcessProtein RegionProteinsProteomeRangeRoleSignal TransductionSiteStarvationStructural ProteinSwissProtSyndromeSystemTechnologyTestingTrainingUbiquitinUbiquitinationValidationVon Hippel-Lindau SyndromeYeastsbasehuman diseaseimprovedmulticatalytic endopeptidase complexnovelubiquitin ligase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Defects in the ubiquitin-proteasome system are implicated in the development of numerous human diseases. Some of the natural substrates for ubiquitination and degradation can induce malignant transformation if not properly removed from the cell. Despite the importance of the ubiquitination process, precise identification of ubiquitination (Ub) sites (i.e. acceptor lysine residues to which a ubiquitin molecule is attached) within substrates of ubiquitin ligases is still experimentally challenging. The development of computational approaches to predict Ub sites from a protein sequence provides an attractive alternative to the experimental methods. Here, we propose to develop a computational algorithm that could predict Ub sites with high precision. First, we will identify new protein Ub sites using a combination of multidimensional protein identification technology (MudPit) and mass spectrometry. Different environmental perturbations, such as heat shock, oxidative stress, DNA damage, and starvation for nutrients, will be introduced in order to increase the coverage of the ubiquitinated proteome. Second, we will use the dataset of new Ub sites to develop a ubiquitination sites predictor. A novel machine learning approach that includes co-training of two predictors having different data representations, and the usage of the unlabeled dataset to increase performance accuracy will be utilized. To our knowledge, this will be the first ubiquitination sites predictor developed to date. Finally, we will apply the predictor to the datasets of cell signaling and cancer-associated proteins to predict new ubiquitination sites and substrates among them. The prediction of intrinsic disorder (ID) will be carried out on the same datasets in order to test the hypothesis about preferential occurrence of Ub sites within ID regions. Annotated disease-related mutations will be extracted from three public databases (MutDB, SWISS-PROT and OMIM) and correlated with the predicted ubiquitination sites. The discovery of mutations in proximity to Ub sites or even those directly affecting Ub sites would lay the basis for formulating and testing biologically meaningful hypotheses about their role in cancer and other diseases. Proteins undergo a wide range of modifications that regulate their activity. One of such modification, ubiquitination, was shown to be involved in various human diseases including cancer, renal diseases (von Hippel-Lindau disease, Liddle syndrome, ischemic acute renal failure), several neurodegenerative diseases (Alzheimer, Parkinson, CAG- expansion disorders). The precise ubiquitination sites in proteins are difficult to detect. We propose to develop a computational approach that could identify such sites with high precision. This would help to develop better drugs that are directed either against the ubiquitinated proteins or against specific sites in these proteins.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1089/cmb.2009.0029
发表时间:
2010-01
期刊:
Journal of computational biology : a journal of computational molecular cell biology
影响因子:
--
作者:
[Vacic V, Iakoucheva LM, Lonardi S, Radivojac P]
通讯作者:
Radivojac P
Loss of post-translational modification sites in disease.
疾病中翻译后修饰位点的丢失。
DOI:
10.1142/9789814295291_0036
发表时间:
2010
期刊:
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing
影响因子:
--
作者:
[Li,Shuyan, Iakoucheva,LiliaM, Mooney,SeanD, Radivojac,Predrag]
通讯作者:
Radivojac,Predrag
DOI:
10.1093/nar/gkj424
发表时间:
2006
期刊:
Nucleic acids research
影响因子:
14.9
作者:
[Haynes C, Iakoucheva LM]
通讯作者:
Iakoucheva LM
DOI:
10.1002/prot.22555
发表时间:
2010-02-01
期刊:
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
影响因子:
2.9
作者:
[Radivojac, Predrag, Vacic, Vladimir, Haynes, Chad, Cocklin, Ross R., Mohan, Amrita, Heyen, Joshua W., Goebl, Mark G., Iakoucheva, Lilia M.]
通讯作者:
Iakoucheva, Lilia M.
Investigating neurodevelopmental toxicity of perfluoroalkyl acids and their derivatives in human brain organoids models
-
批准号:10563204
-
项目类别:
-
资助金额:$60.57万
-
财政年份:2022
-
负责人:LILIA M IAKOUCHEVA
-
依托单位:
Rescue of Cul3 haploinsufficiency phenotypes with CRISPR-mediated Cul3 activation
-
批准号:10527778
-
项目类别:
-
资助金额:$23.7万
-
财政年份:2022
-
负责人:LILIA M IAKOUCHEVA
-
依托单位:
Cortical organoid models to study autism-associated 16p.11.2.CNV
-
批准号:10537569
-
项目类别:
-
资助金额:$70.63万
-
财政年份:2022
-
负责人:LILIA M IAKOUCHEVA
-
依托单位:
Investigating neurodevelopmental toxicity of perfluoroalkyl acids and their derivatives in human brain organoids models
-
批准号:10337517
-
项目类别:
-
资助金额:$60.69万
-
财政年份:2022
-
负责人:LILIA M IAKOUCHEVA
-
依托单位:
Effects of acetaminophen on prenatal brain development: an organoid model
-
批准号:10684055
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2022
-
负责人:LILIA M IAKOUCHEVA
-
依托单位:
Rescue of Cul3 haploinsufficiency phenotypes with CRISPR-mediated Cul3 activation
-
批准号:10672996
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2022
-
负责人:LILIA M IAKOUCHEVA
-
依托单位:
Effects of acetaminophen on prenatal brain development: an organoid model
-
批准号:10510873
-
项目类别:
-
资助金额:$23.7万
-
财政年份:2022
-
负责人:LILIA M IAKOUCHEVA
-
依托单位:
Evaluating the effect of splicing mutations on isoform networks in autism
-
批准号:9912197
-
项目类别:
-
资助金额:$52.0万
-
财政年份:2016
-
负责人:LILIA M IAKOUCHEVA
-
依托单位:
Evaluating the effect of splicing mutations on isoform networks in autism
-
批准号:9101077
-
项目类别:
-
资助金额:$42.04万
-
财政年份:2016
-
负责人:LILIA M IAKOUCHEVA
-
依托单位:
A computational framework for predicting the impact of mutations in autism
-
批准号:8800216
-
项目类别:
-
资助金额:$53.34万
-
财政年份:2014
-
负责人:LILIA M IAKOUCHEVA
-
依托单位:
Protein network of high risk copy number variants for psychiatric disorders
-
批准号:8771945
-
项目类别:
-
资助金额:$22.71万
-
财政年份:2014
-
负责人:LILIA M IAKOUCHEVA
-
依托单位:
Schizophrenia interactome mapping and global discovery of brain splice variants
-
批准号:7949771
-
项目类别:
-
资助金额:$72.2万
-
财政年份:2010
-
负责人:LILIA M IAKOUCHEVA
-
依托单位:
A systems biology approach to unravel theunderlying functional modules of ASD
-
批准号:7844637
-
项目类别:
-
资助金额:$66.31万
-
财政年份:2009
-
负责人:LILIA M IAKOUCHEVA
-
依托单位:
A systems biology approach to unravel theunderlying functional modules of ASD
-
批准号:7941001
-
项目类别:
-
资助金额:$65.6万
-
财政年份:2009
-
负责人:LILIA M IAKOUCHEVA
-
依托单位:
Protein structural disorder and ubiquitination
-
批准号:7256169
-
项目类别:
-
资助金额:$18.8万
-
财政年份:2007
-
负责人:LILIA M IAKOUCHEVA
-
依托单位:
海外基金